Project Grant R56NS129979

Award Date 8/15/23
Completion Date 7/31/24
Dollars Obligated $750K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research at the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to investigate the mechanisms linking traumatic brain injury (TBI) to subsequent neurodegeneration and dementia. The $1,975,262 award will support a 3-year study...
This Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will provide $559,820 to the University of South Carolina to conduct research on the biomechanics of the human brain during high-severity impacts. The goal is to integrate complementary experimental approaches using dynamic MRI and sonomicrometry to fully characterize the intracranial biomechanics of...
The University of Georgia Research Foundation, Inc. (UGA Research Foundation) was awarded a $379,171 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports a 2-year research project to investigate cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury (STBI). Specifically, the project aims to: 1) Characterize...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $102,948.00 to Case Western Reserve University to investigate the link between traumatic brain injury (TBI), hematopoietic stem cell dysfunction, chronic neurodegeneration, and Alzheimer's disease (AD). The key objectives are to assess how acute TBI induces changes to...
This Project Grant award, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to investigate the potential impact of a low-fat, high-fiber diet in limiting traumatic brain injury (TBI)-induced neurodegenerative and inflammatory changes in a mouse model. The $498,713.00 award, with a performance period from July 2024 to June 2027, will support research to...
This federal Project Grant award of $571,404 from the National Institute of Neurological Disorders and Stroke (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) supports research at the University of Pittsburgh focused on developing novel therapies to promote functional recovery after traumatic brain injury (TBI). The key objectives are to investigate how the adipokine hormone adiponectin can protect neurons, restore white matter, and improve cognitive...
The University of South Florida (USF) received a $141,650 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) on September 8, 2023. The research project, titled "Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers", will investigate the effects of nanoscale oligomers of the mutant Huntingtin protein on the properties of lipid...
This $3,109,079 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research at the University of California, Riverside to investigate the role of traumatic brain injury (TBI) across the lifespan in the development of Alzheimer's disease and related dementias (ADRD). The project will use a closed head injury (CHI) TBI mouse model to examine how ADRD risk factors, such as the APOE4 gene and amyloid-beta, interact with TBI at different life stages...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $404,100 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on mechanisms of chronic blood-brain barrier (BBB) dysfunction after traumatic brain injury (TBI). The key focus is to investigate how receptor interacting...
This $2,888,616 Cooperative Agreement award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, will fund a multi-institutional effort to analytically validate a panel of 7 emerging blood-based biomarkers for monitoring the temporal evolution of traumatic brain injury (TBI). The project will leverage existing blood samples from large TBI studies to assess pre-analytical...

The University of South Florida (USF) was awarded a $749,987 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The funding, with an award date of August 15, 2023, supports research to characterize the role of a novel mechanistic pathway involving fibrinogen, sphingolipids, and caveolar transcytosis during traumatic brain injury (TBI) as an example of age-related dementias and cognitive impairment. The research aims to determine how elevated fibrinogen levels enhance cerebrovascular permeability through increased caveolar protein transport, potentially contributing to short-term memory reduction, and whether inhibiting the sphingolipid synthesis pathway can ameliorate these effects. The project will utilize wild-type, hyperfibrinogenemia, and endothelium-specific gene knockout mouse models, along with advanced microscopy techniques, to investigate the underlying mechanisms. Findings from this study may unveil new therapeutic targets for vascular cognitive impairment and dementia.

Generated 8/13/24, 6:48 AM